SCHEMBL29698008

SCHEMBL29698008

CCOc1ccccc1NC(=O)c1ccc(C)c(S(=O)(=O)Nc2ccc(C)cc2)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 7/20 0.61
▸ MEN1 O00255 5/20 0.61
▸ KMT2A Q03164 5/20 0.61
▸ ALDH1A1 P00352 4/20 0.61
▸ NPC1 O15118 2/20 0.59
▸ SMN1; SMN2 Q16637 3/20 0.58
▸ RPA1 P27694 1/20 0.58
▸ GFER P55789 1/20 0.58
▸ TP53 P04637 1/20 0.56
▸ PTGES O14684 1/20 0.56
▸ ALOX5 P09917 1/20 0.56
▸ RAB9A P51151 1/20 0.55
▸ LMNA P02545 2/20 0.55
▸ MRGPRX1 Q96LB2 1/20 0.54
▸ HPGD P15428 3/20 0.54
▸ KDM4E B2RXH2 2/20 0.54
▸ HTT P42858 2/20 0.54
▸ NPY2R P49146 1/20 0.54
▸ NPSR1 Q6W5P4 1/20 0.54
▸ AHR P35869 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16353693 1.00 MAPT (0.61) MAPTMEN1KMT2AALDH1A1NPC1
SCHEMBL14291954 0.86 MAPT (0.68) MAPTMEN1KMT2AALDH1A1NPC1
SCHEMBL13870883 0.82 MEN1 (0.81) MAPTMEN1KMT2AALDH1A1NPC1
SCHEMBL16386084 0.77 NPC1 (0.54) MAPTMEN1KMT2AALDH1A1NPC1
SCHEMBL6403077 0.77 KMT2A (0.81) MAPTMEN1KMT2AALDH1A1NPC1
SCHEMBL27180424 0.76 IDH1 (0.62) MAPTMEN1KMT2AALDH1A1NPC1
SCHEMBL17179708 0.76 MAPT (1.00) MAPTMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL13870881 0.76 MEN1 (0.86) MAPTMEN1KMT2AALDH1A1NPC1
SCHEMBL15919822 0.75 MEN1 (0.78) MAPTMEN1KMT2AALDH1A1NPC1
SCHEMBL13870884 0.74 MEN1 (0.88) MAPTMEN1KMT2AALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4065224-A1 USE OF NEUROPILIN ANTAGONISTS FOR THE TREATMENT OF ENDOMETRIOSIS Institut National de la Santé et de la Recherche Médicale (INSERM) (FR) 2022-10-05 — — EP disclosed
EP-3980012-A1 A NEUROPILIN ANTAGONIST IN COMBINATION WITH A P38ALPHA-KINASE INHIBITOR FOR THE TREATMENT OF CANCER Institut National de la Santé et de la Recherche Médicale (INSERM) (FR) 2022-04-13 — — EP disclosed
Send feedback